| Tyler Storey, | |
|
2500 S State St, South Salt Lake, UT 84115-3164 | |
| (385) 646-5000 | |
| Not Available |
| Full Name | Tyler Storey |
|---|---|
| Gender | Male |
| Speciality | Psychologist - School |
| Location | 2500 S State St, South Salt Lake, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326765751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TS0200X | Psychologist - School | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tyler Storey, 616 Arlington Dr, Provo, UT 84606-6669 Ph: () - | Tyler Storey, 2500 S State St, South Salt Lake, UT 84115-3164 Ph: (385) 646-5000 |
News Archive
Adhering to a certain diet may help postpone the need for dialysis in patients with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Patients undergoing long-term treatment with steroids may suffer from metabolic side effects. Researchers at the Helmholtz Zentrum München and the Ludwig Maximilians University of Munich, partners in the German Center for Diabetes Research, have now pinpointed a mechanism that leads to so-called steroid diabetes
Prof. Smadar Cohen, head of the University's Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, has been awarded the prestigious Rappaport Prize for Excellence in Biomedical Research, an award totaling $100,000. The prize, given by Israel's Rappaport Foundation, is presented annually to a researcher whose research has either significantly advanced or has the potential to significantly advance any medical or biomedical field.
Visa Inc. and Visa Europe today announced support for "Operation Pangea III," a global law enforcement action coordinated by INTERPOL targeting the online sale of counterfeit and illegal medicines resulting in arrests across the globe and the seizure of thousands of potentially harmful medicines.
Teva Pharmaceutical Industries Ltd. and APP Pharmaceuticals, Inc. announced today the commercial launch of Gemcitabine HCI for Injection in 200 mg and 1 g single dose vials, the generic version of Gemzar®, in the United States, pursuant to a commercialization, manufacture and supply agreement signed by the two companies.
› Verified 2 days ago
Dr. Victoria Rose Hatton, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2500 S State St, South Salt Lake, UT 84115 Phone: 385-646-5000 | |
Nicole Feigt, ED.S, MS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2500 S State St, South Salt Lake, UT 84115 Phone: 385-646-5000 | |
Mrs. Autumn Seraphina Talbott-cisneros, MS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2500 S State St, South Salt Lake, UT 84115 Phone: 385-646-5000 | |
Chloe Ruebeck Marr, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2500 S State St, South Salt Lake, UT 84115 Phone: 385-646-8240 | |
Heather Elise Creel, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2500 S State St, South Salt Lake, UT 84115 Phone: 385-646-5000 | |
Taylor Jackson, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2500 S State St, South Salt Lake, UT 84115 Phone: 385-646-5000 | |
Bethany Sue Ortiz, EDS, NCSP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2500 S State St, South Salt Lake, UT 84115 Phone: 385-646-1641 |